Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Jun;9(6):2537.
doi: 10.1016/j.jaip.2021.02.061.

How important is the second dose of the COVID-19 mRNA vaccine?

Anne Y Liu  1
Affiliations
Comment

How important is the second dose of the COVID-19 mRNA vaccine?

Anne Y Liu. J Allergy Clin Immunol Pract. 2021 Jun.
No abstract available

PubMed Disclaimer

Comment in

  • Reply to "How important is the second dose of the COVID-19 mRNA vaccine?".
    Shaker MS, Phillips E, Blumenthal KG, Abrams EM, Banerji A, Oppenheimer J, Vander Leek TK, Mack DP, Wickner PG, Singer AG, Khan DA, Greenhawt M. Shaker MS, et al. J Allergy Clin Immunol Pract. 2021 Jun;9(6):2537-2539. doi: 10.1016/j.jaip.2021.03.016. J Allergy Clin Immunol Pract. 2021. PMID: 34112481 Free PMC article. No abstract available.

Comment on

References

    1. Banerji A., Wickner P.G., Saff R., Stone C.A., Robinson L.B., Long A.A., et al. mRNA vaccines to prevent COVID-19 disease and reported allergic reactions: current evidence and suggested approach. J Allergy Clin Immunol Pract. 2021;9:1423–1437. - PMC - PubMed
    1. Greenhawt M., Abrams E.M., Oppenheimer J., Vander Leek T.K., Mack D.P., Singer A.G., et al. The COVID-19 pandemic in 2021: avoiding overdiagnosis of anaphylaxis risk while safely vaccinating the world. J Allergy Clin Immunol Pract. 2021;9:1438–1441. - PMC - PubMed
    1. Optimising the COVID-19 vaccination programme for maximum short-term impact: short statement from the Joint Committee on Vaccination and Immunisation (JCVI). 2020. 2020. https://app.box.com/s/uwwn2dv4o2d0ena726gf4403f3p2acnu Available from: Accessed February 4, 2021.
    1. ModernaTX, Inc FDA briefing document: Moderna COVID-19 Vaccine. 2020. 2020. https://www.fda.gov/media/144434/download Available from: Accessed February 4, 2021.
    1. Voysey M., Costa Clemens S.A., Madhi S.A., Weckx L.Y., Folegatti P.M., Aley P.K., et al. Oxford COVID Vaccine Trial Group. Single dose administration, and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine. Lancet. 2021;397:881–891. - PMC - PubMed